Update of National Diagnostic Reference Levels for Adult CT in Switzerland and Assessment of Radiation Dose Reduction Since 2010
Overview
Affiliations
Objectives: To update the national diagnostic reference levels (DRLs) for adult CT in Switzerland using dose management software and to compare them to the previous Swiss DRLs from 2010.
Methods: CT dose data from 14 radiological institutes with a total of 50 CT scanners were collected with locally installed dose management software between 2014 and 2017. Data were assigned to 15 defined master protocols. Data cleaning steps were developed and adjusted individually for each participating institute and protocol. The DRLs for each master protocol were calculated as the 75th percentile of the distribution of the median volume computed tomography dose index (CTDI) and dose-length product (DLP) values per CT scanner.
Results: In total, 220,269 CT exams were available after data cleaning. Updated DRLs showed a clear trend towards lower doses compared with previous DRLs. The average relative change in the DRLs for CTDI was - 30% (0 to - 47%) and - 22% for DLP (+ 20 to - 40%). The largest relative decrease in the DRL for DLP was observed for the cervical spine protocol (- 40%), the two chest protocols (chest, - 37%; and exclusion of pulmonary embolism, - 33%), and the two neck protocols (neck, - 32%; and carotid angiography, - 28%). The DRLs for other protocols, for example the head and the abdomen-pelvis protocol, showed smaller relative changes (- 11% and - 17%).
Conclusions: The updated national DRLs are substantially lower than the previous values from 2010, demonstrating technological progress and the efforts of the radiological community to lower CT radiation exposure.
Key Points: • Dose management software allows the establishment of DRLs based on big data. • Updated Swiss DRLs for adult CT are substantially lower compared with those from 2010. • Swiss DRLs are low compared with other national DRLs.
Yagahara A, Ando D, Oda M Sci Rep. 2024; 14(1):2249.
PMID: 38278840 PMC: 10817891. DOI: 10.1038/s41598-024-52294-y.
Aldahery S Saudi Pharm J. 2023; 31(11):101820.
PMID: 37928978 PMC: 10622684. DOI: 10.1016/j.jsps.2023.101820.
Kahraman G, Haberal K, Agildere A Diagn Interv Radiol. 2023; 30(3):205-211.
PMID: 37650522 PMC: 11095070. DOI: 10.4274/dir.2023.232265.
Widmann G, Beyer A, Jaschke W, Luger A, Zoller H, Tilg H Eur J Radiol Open. 2023; 10:100470.
PMID: 36590327 PMC: 9800257. DOI: 10.1016/j.ejro.2022.100470.
Tonkopi E, Wikan E, Hovland T, Hogset S, Kofod T, Sefenu S Acta Radiol Open. 2022; 11(10):20584601221131477.
PMID: 36225897 PMC: 9549116. DOI: 10.1177/20584601221131477.